Literature DB >> 18275951

The vasopressin system--from antidiuresis to psychopathology.

Elisabeth Frank1, Rainer Landgraf.   

Abstract

Vasopressin is a neuropeptide with multiple functions. In addition to its predominantly antidiuretic action after peripheral secretion from the posterior pituitary, it seems to fulfill--together with its receptor subtype--all requirements for a neuropeptide system critically involved in higher brain functions, including cognitive abilities and emotionality. Following somatodendritic and axonal release in distinct brain areas, vasopressin acts as a neuromodulator and neurotransmitter in multiple and varying modes of interneuronal communication. Accordingly, changes in vasopressin expression and release patterns may have wide-spread consequences. As shown in mice, rats, voles, and humans, central vasopressin release along a continuum may be beneficial to the individual, serving to adjust physiology and behavior in stressful scenarios, possibly at the potential expense of increasing susceptibility to disease. Indeed, if over-expressed and over-released, it may contribute to hyper-anxiety and depression-like behaviors. A vasopressin deficit, in turn, may cause signs of both diabetes insipidus and total hypo-anxiety. The identification of genetic polymorphisms underlying these phenomena does not only explain individual variation in social memory and emotionality, but also help to characterize potential targets for therapeutic interventions. The capability of both responding to stressful stimuli and mediating genetic polymorphisms makes the vasopressin system a key mediator for converging (i.e., environmentally and genetically driven) behavioral regulation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18275951     DOI: 10.1016/j.ejphar.2007.11.063

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  39 in total

1.  Oxytocin, vasopressin and estrogen receptor gene expression in relation to social recognition in female mice.

Authors:  Amy E Clipperton-Allen; Anna W Lee; Anny Reyes; Nino Devidze; Anna Phan; Donald W Pfaff; Elena Choleris
Journal:  Physiol Behav       Date:  2011-11-03

2.  Interaction of stress, corticotropin-releasing factor, arginine vasopressin and behaviour.

Authors:  Eléonore Beurel; Charles B Nemeroff
Journal:  Curr Top Behav Neurosci       Date:  2014

3.  Oxytocin in survivors of childhood-onset craniopharyngioma.

Authors:  Anna M M Daubenbüchel; Anika Hoffmann; Maria Eveslage; Jale Özyurt; Kristin Lohle; Julia Reichel; Christiane M Thiel; Henri Martens; Vincent Geenen; Hermann L Müller
Journal:  Endocrine       Date:  2016-09-01       Impact factor: 3.633

4.  Modulation of parvalbumin interneuron number by developmentally transient neocortical vasopressin receptor 1a (V1aR).

Authors:  E A D Hammock; P Levitt
Journal:  Neuroscience       Date:  2012-07-20       Impact factor: 3.590

5.  Central vasopressin V1A receptor blockade impedes hypothalamic-pituitary-adrenal habituation to repeated restraint stress exposure in adult male rats.

Authors:  Megan Gray; Leyla Innala; Victor Viau
Journal:  Neuropsychopharmacology       Date:  2012-07-25       Impact factor: 7.853

6.  Chronic Hyponatremia Causes Neurologic and Psychologic Impairments.

Authors:  Haruki Fujisawa; Yoshihisa Sugimura; Hiroshi Takagi; Hiroyuki Mizoguchi; Hideyuki Takeuchi; Hisakazu Izumida; Kohtaro Nakashima; Hiroshi Ochiai; Seiji Takeuchi; Atsushi Kiyota; Kazuya Fukumoto; Shintaro Iwama; Yoshiko Takagishi; Yoshitaka Hayashi; Hiroshi Arima; Yukio Komatsu; Yoshiharu Murata; Yutaka Oiso
Journal:  J Am Soc Nephrol       Date:  2015-09-16       Impact factor: 10.121

7.  WAY 267,464, a non-peptide oxytocin receptor agonist, impairs social recognition memory in rats through a vasopressin 1A receptor antagonist action.

Authors:  Callum Hicks; Linnet Ramos; Tristan A Reekie; Rajeshwar Narlawar; Michael Kassiou; Iain S McGregor
Journal:  Psychopharmacology (Berl)       Date:  2015-03-13       Impact factor: 4.530

8.  Amphiphysin I but not dynamin I nor synaptojanin mRNA expression increased after repeated methamphetamine administration in the rat cerebrum and cerebellum.

Authors:  Mitsuko Hamamura; Jiro Okouchi; Hidetoshi Ozawa; Yoshihiko Kimuro; Akiko Iwaki; Yasuyuki Fukumaki
Journal:  J Neural Transm (Vienna)       Date:  2012-12-08       Impact factor: 3.575

9.  Interaction of oxytocin level and past depression may predict postpartum depressive symptom severity.

Authors:  Suena H Massey; Stephanie A Schuette; Hossein Pournajafi-Nazarloo; Katherine L Wisner; C Sue Carter
Journal:  Arch Womens Ment Health       Date:  2016-03-08       Impact factor: 3.633

10.  An intrinsic vasopressin system in the olfactory bulb is involved in social recognition.

Authors:  Vicky A Tobin; Hirofumi Hashimoto; Douglas W Wacker; Yuki Takayanagi; Kristina Langnaese; Celine Caquineau; Julia Noack; Rainer Landgraf; Tatsushi Onaka; Gareth Leng; Simone L Meddle; Mario Engelmann; Mike Ludwig
Journal:  Nature       Date:  2010-02-24       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.